The fate of medications evaluated for ischemic stroke pharmacotherapy over the period 1995-2015
about
Intravenous thrombolysis for acute ischemic stroke: a bridge between two centuries.Hi1a as a Novel Neuroprotective Agent for Ischemic Stroke by Inhibition of Acid-Sensing Ion Channel 1a.Condition-specific transcriptional regulation of neuronal ion channel genes in brain ischemia.Protecting Oligodendrocytes by Targeting Non-Glutamate Receptors as a New Therapeutic Strategy for Ischemic Stroke.
P2860
The fate of medications evaluated for ischemic stroke pharmacotherapy over the period 1995-2015
description
2016 nî lūn-bûn
@nan
2016 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
The fate of medications evalua ...... rapy over the period 1995-2015
@ast
The fate of medications evalua ...... rapy over the period 1995-2015
@en
The fate of medications evalua ...... rapy over the period 1995-2015
@nl
type
label
The fate of medications evalua ...... rapy over the period 1995-2015
@ast
The fate of medications evalua ...... rapy over the period 1995-2015
@en
The fate of medications evalua ...... rapy over the period 1995-2015
@nl
prefLabel
The fate of medications evalua ...... rapy over the period 1995-2015
@ast
The fate of medications evalua ...... rapy over the period 1995-2015
@en
The fate of medications evalua ...... rapy over the period 1995-2015
@nl
P2860
P3181
P1476
The fate of medications evalua ...... rapy over the period 1995-2015
@en
P2093
Kewei Wang
Xiaoling Chen
P2860
P304
P3181
P356
10.1016/J.APSB.2016.06.013
P407
P577
2016-11-01T00:00:00Z